Home › Calculator › INM Dividend Calculator 2026
INM Dividend DRIP Calculator 2026
125.79% YieldHealthcareInMed Pharmaceuticals Inc. · NASDAQ
Price: $1.59 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When INM pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your INM snowball 📈
$10,000 in INM → $34.43M in 10 years · $1,598,554.85/month
About InMed Pharmaceuticals Inc. (INM) — Dividend Analysis 2026
InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary product, INM-755, is a cannabinol-infused topical cream that is currently progressing through its second Phase I clinical trial for the management of epidermolysis bullosa. Beyond this lead candidate, the company is also developing INM-088, which is undergoing preclinical studies for glaucoma treatment, and INM-405, intended for pain relief. Its broader development pipeline encompasses cannabinoid-based interventions for a variety of medical conditions, with a particular focus on dermatological and ocular disorders. Furthermore, InMed is involved in critical IND-enabling pharmacology and preclinical toxicology research. It is also pioneering IntegraSyn, an innovative integrated biosynthesis approach designed to produce pharmaceutical-grade cannabinoids efficiently. The company maintains a research partnership with BayMedica Inc. to collaborate on the formulation and assessment of novel cannabinoid therapeutics. Established in 1981, the company is headquartered in Vancouver, Canada. It operated under the name Cannabis Technologies Inc. before officially rebranding as InMed Pharmaceuticals Inc. in October 2014.
Compare INM with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full INM DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open INM position with:
🌍 INM Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold INM.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 125.79% | 122.99% | $12,579 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 106.92% | 104.12% | $10,692 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 100.63% | 97.83% | $10,063 / yr |
| 🇬🇧 UK ISA | 0% | 125.79% | 122.99% | $12,579 / yr |
| 🇬🇧 UK Taxable | 8.75% | 114.78% | 111.98% | $11,478 / yr |
| 🇨🇦 TFSA | 0% | 125.79% | 122.99% | $12,579 / yr |
| 🇨🇦 CA Taxable | 25% | 94.34% | 91.54% | $9,434 / yr |
| 🇦🇺 Super (pension) | 15% | 106.92% | 104.12% | $10,692 / yr |
| 🇦🇺 AU Taxable | 30% | 88.05% | 85.25% | $8,805 / yr |
| 🇩🇪 DE Taxable | 26.375% | 92.61% | 89.81% | $9,261 / yr |
| 🇫🇷 FR Taxable | 30% | 88.05% | 85.25% | $8,805 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 INM Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 INM Dividend Payment Schedule
INM pays quarterly — 4 times per year. Next ex-div: TBD.
📊 INM vs Healthcare Benchmarks
How INM compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for INM sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ INM Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-07-15 | 1,000 | $1.55 | $1.6K | ||
| Buy | 2026-07-16 | 19 | $1.55 | $29.00 | ||
| Buy | 2026-07-15 | 13,761 | $1.55 | $21.3K | ||
| Buy | 2026-07-14 | 4,882 | $1.55 | $7.6K | ||
| Buy | 2026-07-16 | 2 | $1.55 | $3.00 | ||
| Buy | 2026-07-15 | 1,389 | $1.55 | $2.2K | ||
| Buy | 2026-07-14 | 493 | $1.55 | $764.00 | ||
| Buy | 2026-07-02 | 1,460 | $1.55 | $2.3K | ||
| Buy | 2026-07-01 | 3,946 | $1.55 | $6.1K | ||
| Buy | 2026-06-30 | 545 | $1.54 | $839.00 |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the INM dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
InMed Pharmaceuticals Inc. (INM) is currently trading at $1.59, 100% below its 52-week high. The current dividend yield is 125.79% based on an annual payout of $2.00 per share.
INM (InMed Pharmaceuticals Inc.) — 125.79% Dividend Yield Analysis
InMed Pharmaceuticals Inc. (INM) is a healthcare stock currently trading at $1.59 with a dividend yield of 125.79%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (125.79%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.